GlassScriptPhysician profile
Sarah E Hart
NPI 1609126200
$2,728.79
in general payments reported to CMS, 2019-2025
25 companies · $1,058 in 2025
The $1,058 reported for 2025 was more than what 86% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $14.19 · 2022: $71.50 · 2023: $188 · 2024: $1,397 · 2025: $1,058.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,643.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,643.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $468.11 | 2023-2025 | Gemtesa, Orgovyx |
| Janssen Biotech, INC. | $377.59 | 2023-2025 | Erleada, Akeega |
| 180 Medical, INC. | $290.86 | 2023-2025 | |
| Abbvie INC. | $275.88 | 2023-2025 | |
| Procept Biorobotics Corporation | $163.19 | 2024-2025 | Aquabeam System |
| Pfizer INC. | $153.94 | 2024-2025 | |
| Janssen Pharmaceuticals, INC | $122.96 | 2022-2023 | Xarelto |
| Progenics Pharmaceuticals, INC. | $112.80 | 2024-2025 | |
| Myriad Genetic Laboratories, INC. | $109.64 | 2024-2025 | Prolaris |
| Astellas Pharma US INC | $84.28 | 2023-2025 | Xtandi, Myrbetriq |
| Merck Sharp & Dohme LLC | $81.93 | 2024-2025 | Keytruda, Lynparza, Welireg |
| Olympus America INC. | $72.41 | 2025 | Itind System |
| Tolmar, INC. | $62.75 | 2024-2025 | Jatenzo, Eligard |
| Blue Earth Diagnostics | $52.58 | 2024-2025 | Posluma |
| Koelis INC. | $48.07 | 2023-2024 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ipsen Biopharmaceuticals, INC | $45.42 | 2025 | Iqirvo |
| Teleflex LLC | $37.92 | 2024 | Urolift |
| Urogen Pharma, INC. | $33.68 | 2024-2025 | |
| Immunitybio, INC. | $30.24 | 2025 | |
| Vertex Pharmaceuticals Incorporated | $27.78 | 2025 | |
| Photocure INC | $17.00 | 2024 | Cysview |
| Bayer Healthcare Pharmaceuticals INC. | $16.89 | 2023 | |
| Coloplast Corp | $15.08 | 2024 | |
| Gilead Sciences, INC. | $14.19 | 2021 | |
| Medtronic, INC. | $13.60 | 2024 | Kyphon Express II Kyphopak Tray |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Hart listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.